RNA seq of SiHa WT vs IFITM1/3 KO
Data files
Feb 24, 2022 version files 19.45 GB
-
Expression.csv
4.35 MB
-
index13_AGTCAA_L001-L002_R1_001.fastq.gz
2.45 GB
-
index13_AGTCAA_L001-L002_R2_001.fastq.gz
2.50 GB
-
index14_AGTTCC_L001-L002_R1_001.fastq.gz
1.52 GB
-
index14_AGTTCC_L001-L002_R2_001.fastq.gz
1.53 GB
-
index23_GAGTGG_L001-L002_R1_001.fastq-001.gz
2.52 GB
-
index23_GAGTGG_L001-L002_R2_001.fastq-002.gz
2.55 GB
-
index25_ACTGAT_L001-L002_R1_001.fastq.gz
3.18 GB
-
index25_ACTGAT_L001-L002_R2_001.fastq.gz
3.21 GB
-
README.txt
1.55 KB
Abstract
IFITM proteins play a role in cancer cell progression through undefined mechanisms. Here, we propose an emergent role of IFITM1/3 regulating protein synthesis. SBP tagged IFITM1 protein was used to identify an association of IFITM1 protein with the cytosolic isoform of SRSF1 that transports mRNA to the ribosome. This cytosolic association was confirmed in situ using proximity ligation assays for SRSF1 and IFITM1/3, suggesting a role associated with translation. Accordingly, IFITM1/3 were shown to interact with HLA-B mRNA in response to IFNγ stimulation using RNA-protein proximity ligation assays. In addition, shotgun RNA sequencing in IFITM1/IFITM3 null cells and wt-SiHa cells indicated that reduced HLA-B gene expression does not account for lowered HLA-B protein synthesis in response to IFNγ. Furthermore, ribosome profiling using sucrose gradient sedimentation identified a reduction in 80S ribosomal fraction an IFITM1/IFITM3 null cells compared to their wild-type counterpart, partially reverted by IFITM1/3 complementation. Our data all together link the binding of IFITM1/3 proteins to HLA-B mRNA and SRSF1 as a mechanism to catalyze the synthesis of target proteins, suggesting an RNA chaperonin role for IFITM1/3 proteins.